As of 2024-12-15, the Intrinsic Value of Magellan Health Inc (MGLN) is
255.92 USD. This MGLN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 94.99 USD, the upside of Magellan Health Inc is
169.40%.
The range of the Intrinsic Value is 157.28 - 965.68 USD
255.92 USD
Intrinsic Value
MGLN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
157.28 - 965.68 |
255.92 |
169.4% |
| DCF (Growth 10y) |
214.39 - 1,290.63 |
346.58 |
264.9% |
| DCF (EBITDA 5y) |
195.22 - 237.24 |
218.05 |
129.5% |
| DCF (EBITDA 10y) |
233.30 - 307.67 |
270.41 |
184.7% |
| Fair Value |
5.43 - 5.43 |
5.43 |
-94.28% |
| P/E |
14.50 - 207.61 |
87.66 |
-7.7% |
| EV/EBITDA |
74.55 - 90.54 |
83.21 |
-12.4% |
| EPV |
93.31 - 129.75 |
111.53 |
17.4% |
| DDM - Stable |
(1.31) - (6.46) |
(3.88) |
-104.1% |
| DDM - Multi |
115.54 - 444.47 |
183.51 |
93.2% |
MGLN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,459.29 |
| Beta |
1.03 |
| Outstanding shares (mil) |
25.89 |
| Enterprise Value (mil) |
1,865.16 |
| Market risk premium |
4.24% |
| Cost of Equity |
7.12% |
| Cost of Debt |
8.31% |
| WACC |
6.62% |